Axa Buys 21,900 Shares of RealNetworks Inc (RNWK)

Axa increased its stake in shares of RealNetworks Inc (NASDAQ:RNWK) by 13.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 187,300 shares of the technology company’s stock after buying an additional 21,900 shares during the quarter. Axa owned 0.50% of RealNetworks worth $641,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Northern Trust Corp grew its holdings in RealNetworks by 18.0% during the second quarter. Northern Trust Corp now owns 291,171 shares of the technology company’s stock worth $1,260,000 after buying an additional 44,387 shares in the last quarter. State Street Corp grew its holdings in RealNetworks by 6.2% during the second quarter. State Street Corp now owns 470,564 shares of the technology company’s stock worth $2,038,000 after buying an additional 27,268 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its holdings in RealNetworks by 80.3% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 95,855 shares of the technology company’s stock worth $328,000 after buying an additional 42,680 shares in the last quarter. Institutional investors and hedge funds own 52.64% of the company’s stock.

How to Become a New Pot Stock Millionaire

Separately, ValuEngine upgraded RealNetworks from a “sell” rating to a “hold” rating in a report on Thursday, March 1st.

Shares of RealNetworks stock opened at $3.14 on Friday. RealNetworks Inc has a 1-year low of $2.63 and a 1-year high of $5.00. The stock has a market capitalization of $113.89, a price-to-earnings ratio of -7.14 and a beta of 0.46.

RealNetworks (NASDAQ:RNWK) last announced its quarterly earnings results on Wednesday, February 7th. The technology company reported ($0.11) earnings per share (EPS) for the quarter. The company had revenue of $18.87 million for the quarter. RealNetworks had a negative return on equity of 26.17% and a negative net margin of 14.49%.

In other RealNetworks news, CFO Cary Baker acquired 35,816 shares of RealNetworks stock in a transaction on Thursday, March 1st. The stock was purchased at an average price of $2.93 per share, for a total transaction of $104,940.88. Following the purchase, the chief financial officer now directly owns 18,266 shares of the company’s stock, valued at $53,519.38. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 37.90% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This piece was reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3298251/axa-buys-21900-shares-of-realnetworks-inc-rnwk.html.

RealNetworks Profile

RealNetworks, Inc creates applications and services that enable to connect with digital media. The Company connects consumers with their digital media directly and through partners, focusing on supporting various network, devices, media types and social networks. It operates through three segments: Consumer Media, Mobile Services and Games.

Institutional Ownership by Quarter for RealNetworks (NASDAQ:RNWK)

Receive News & Ratings for RealNetworks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RealNetworks and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Esperion Therapeutics  PT Raised to $121.00 at Northland Securities
Esperion Therapeutics PT Raised to $121.00 at Northland Securities
Darrel S. Purdy Sells 3,500 Shares of Paramount Resources  Stock
Darrel S. Purdy Sells 3,500 Shares of Paramount Resources Stock
Antibe Therapeutics Inc  Director Sells C$74,750.40 in Stock
Antibe Therapeutics Inc Director Sells C$74,750.40 in Stock
Unit  Earning Somewhat Positive Press Coverage, Study Shows
Unit Earning Somewhat Positive Press Coverage, Study Shows
Oleg M. Pohotsky Buys 10,000 Shares of New America High Income Fund Inc.  Stock
Oleg M. Pohotsky Buys 10,000 Shares of New America High Income Fund Inc. Stock
Revance Therapeutics  Given News Impact Score of 0.22
Revance Therapeutics Given News Impact Score of 0.22


© 2006-2018 Ticker Report. Google+.